Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country

FERNANDO CÁCERES; SANDRA VANOTTI; STEPHEN RAO; CRESPO E; ARGUELLO G; ZAPATA M; TORRES P; BRIZUELA J; SONIA C; BALLARIO C; SEGURA D; SINAY V; PELLI NOBLE RF; CÁCERES M; RODRÍGUEZ L; ZUIN D; FERNÁNDEZ J; JORGE CORREALE; FACUNDO MANES; LÓPEZ AM; GEREMÍA C; NOFAL P; PÁEZ MF; MUÑOZ D; SECCHI J; SAREDO G; LOVELL V; AMORES M; COLOMBO O; PIEDRABUENA R; GIOBELLINO R; FERNÁNDEZ LIGUORI N; GARCEA O; ANTONELLI M; AYUSO L; BARCELLONE M; BRIZUELA P; CAGNOLO N; CASTAGNA M; CUEVAS A; GABLIARDI M; LEVY M; MARTINI M; MILANESIO J; ORTIZ C; PAJÓN G; PELUFO M; RAMÍREZ M; RIVADENEIRA M; SCIOSCIA A; SCIOSCIA M; SECCHI F; STRUMIA M; TAUSSIK I; TUMMINELLO G; USSHER C

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

TAYLOR & FRANCIS INC

Lugar: Londres; Año: 2011 vol. 33 p. 1094 - 1098

1380-3395

We assessed cognitive performance and physical disability in 111 multiple sclerosis (MS) patients and 222 healthy controls in a multicenter study in Argentina to obtain the prevalence of cognitive impairment (CI) in a population of MS outpatients in Argentina. MS patients presented significantly lower scores in all Brief Repeatable Battery of Neuropsychology (BRB-N) tests than did the control group. The prevalence of CI was 43.2%. This study allowed us to obtain actual figures on the number of MS patients with CI in a Latin American sample. This validation is a very useful tool for clinical practice and for research studies to assess cognition in MS.